on Vitruvia Medical AG (isin : CH0461931419)
Vitruvia Medical AG: Half-Year Results as of June 30, 2024
Vitruvia Medical AG released its half-year results for the period ending June 30, 2024. The results align with expectations. The Board of Directors maintains the full-year forecast.
For the first half of 2024, Vitruvia Medical AG reported a loss of CHF 52,968.06. This is an improvement compared to the CHF 150,464.24 loss recorded in the previous year. The management reaffirms the outlook for the remainder of the year.
The Board of Directors predicts consolidated sales will reach around EUR 2.0 million for the full year. An ongoing improvement in earnings is anticipated compared to last year.
R. P.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Vitruvia Medical AG news